Clear All
12159 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
67046-1524-03 67046-1524 Methotrexate Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Feb 27, 2025 In Use
45963-0734-74 45963-0734 Docetaxel Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Sep 1, 2014 Jul 31, 2017 In Use
67457-0358-10 67457-0358 Epirubicin Hydrochloride Epirubicin Hydrochloride 200.0 mg/100mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jul 31, 2013 Apr 30, 2015 No Longer Used
54868-4339-03 54868-4339 Melphalan Alkeran Chemotherapy Alkylating Agent Nitrogen Mustard Oral Aug 15, 2005 Jun 30, 2012 No Longer Used
70255-0025-05 70255-0025 Encorafenib BRAFTOVI 75.0 mg/1 Chemotherapy BRAF Inhibitor V600E Oral Aug 3, 2020 In Use
10139-0063-50 10139-0063 Fluorouracil Fluorouracil Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Aug 21, 2012 Jun 30, 2014 No Longer Used
00143-9093-01 00143-9093 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jan 19, 2018 In Use
65219-0552-02 65219-0552 Pralatrexate Pralatrexate 40.0 mg/2mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous Nov 15, 2022 In Use
21922-0049-17 21922-0049 Fluorouracil FLUOROURACIL 2.0 g/40g Chemotherapy Antimetabolite Pyrimidine Analog Topical Feb 14, 2025 In Use
61703-0408-25 61703-0408 Methotrexate Methotrexate 25.0 mg/mL Chemotherapy Antimetabolite Folic Acid Analog Intra-arterial, Intramuscular, Intrathecal, Intravenous, Subcutaneous Nov 11, 2013 In Use
72266-0162-01 72266-0162 Oxaliplatin Oxaliplatin 5.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Mar 30, 2020 In Use
16729-0276-67 16729-0276 Fluorouracil Fluorouracil 50.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Mar 14, 2014 In Use
00093-7639-41 00093-7639 Temozolomide Temozolomide 180.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug 12, 2013 Jul 31, 2019 In Use
62856-0001-10 62856-0001 Altretamine Hexalen 50.0 mg/1 Chemotherapy Alkylating Agent Triazines Oral Dec 26, 1990 Dec 31, 2019 No Longer Used
31722-0412-14 31722-0412 TEMOZOLOMIDE TEMOZOLOMIDE 20.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Aug 23, 2024 In Use
71288-0114-50 71288-0114 GEMCITABINE HYDROCHLORIDE GEMCITABINE 1.0 g/1 Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Nov 1, 2018 In Use
00078-0666-15 00078-0666 Trametinib Mekinist 0.5 mg/1 Chemotherapy MEK Inhibitor BRAF Oral Mar 17, 2016 Oct 31, 2023 No Longer Used
73207-0302-41 73207-0302 Vimseltinib ROMVIMZA 14.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor CSF1R Oral Feb 14, 2025 In Use
55390-0142-10 55390-0142 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jul 13, 1998 Oct 31, 2012 No Longer Used
80725-0630-25 80725-0630 Thioguanine TABLOID 40.0 mg/1 Chemotherapy Antimetabolite Purine Analog Oral May 15, 2023 In Use
47335-0891-75 47335-0891 Temozolomide Temozolomide 20.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Feb 13, 2014 In Use
60505-6435-00 60505-6435 Eribulin mesylate Eribulin mesylate 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Mar 19, 2025 In Use
82293-0017-10 82293-0017 Sunitinib Malate Sunitinib Malate 50.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FLT, PDGFR, KIT, RET, CSF Oral May 1, 2024 In Use
63323-0126-00 63323-0126 GEMCITABINE GEMCITABINE 2.0 g/50mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous May 17, 2011 In Use
72694-0879-10 72694-0879 Vorasidenib VORANIGO 10.0 mg/1 Chemotherapy IDH Inhibitor IDH1, IDH2 Oral Aug 7, 2024 In Use

Found 12159 results — Export these results